NASDAQ:MTOX - MEDTOX Scientific Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MEDTOX Scientific, Inc. (MEDTOX) operates through its wholly owned subsidiaries, MEDTOX Laboratories, Inc. (MEDTOX Laboratories), MEDTOX Diagnostics, Inc. (MEDTOX Diagnostics) and New Brighton Business Center, LLC (NBBC). MEDTOX Laboratories provides forensic and clinical laboratory services. MEDTOX Diagnostics manufactures and distributes diagnostic devices and other similar products. During the year ended December 31, 2011, MEDTOX Laboratories and MEDTOX Diagnostics accounted for 79% and 21% of the Company's revenues, respectively. The Company operates in two segments: Laboratory Services, which consists of the activities conducted by MEDTOX Laboratories and NBBC, and Product Sales conducted by MEDTOX Diagnostics. During the year ended December 31, 2011, the Company introduced its EZ-Screen Cup product. The EZ-Screen Cup is targeted for the government, corporate and occupational health clinic markets. On July 31, 2012, Laboratory Corporation of America Holdings acquired MEDTOX.

Receive MTOX News and Ratings via Email

Sign-up to receive the latest news and ratings for MTOX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:MTOX
Previous Symbol
CUSIPN/A
Phone+1-612-6367466

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

MEDTOX Scientific (NASDAQ:MTOX) Frequently Asked Questions

What is MEDTOX Scientific's stock symbol?

MEDTOX Scientific trades on the NASDAQ under the ticker symbol "MTOX."

Has MEDTOX Scientific been receiving favorable news coverage?

Media stories about MTOX stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. MEDTOX Scientific earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave media stories about the healthcare company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of MEDTOX Scientific?

Shares of MTOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MEDTOX Scientific's official website?

The official website for MEDTOX Scientific is http://www.medtox.com/.

How can I contact MEDTOX Scientific?

MEDTOX Scientific's mailing address is 402 County Road D W, SAINT PAUL, MN 55112-3522, United States. The healthcare company can be reached via phone at +1-612-6367466.


MarketBeat Community Rating for MEDTOX Scientific (NASDAQ MTOX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about MEDTOX Scientific and other stocks. Vote "Outperform" if you believe MTOX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTOX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel